EquityEquity - OtherVery High Risk
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹1,673 Cr
Expense Ratio
0.41%
ISIN
INF109KC17V7
Minimum SIP
-
Exit Load
-
Inception Date
12 Aug 2020
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-1.04%
— (Cat Avg.)
3 Years
+15.07%
— (Cat Avg.)
Since Inception
+22.93%
— (Cat Avg.)
Equity | ₹1,672.82 Cr | 100.00% |
Others | ₹0.04 Cr | 0.00% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹85.24 Cr | 5.10% |
Bharti Airtel Ltd | Equity | ₹83.09 Cr | 4.97% |
ICICI Bank Ltd | Equity | ₹74.71 Cr | 4.47% |
Divi's Laboratories Ltd | Equity | ₹72 Cr | 4.30% |
Pidilite Industries Ltd | Equity | ₹64.6 Cr | 3.86% |
Lupin Ltd | Equity | ₹62.34 Cr | 3.73% |
United Spirits Ltd | Equity | ₹61.1 Cr | 3.65% |
Grasim Industries Ltd | Equity | ₹59.69 Cr | 3.57% |
Britannia Industries Ltd | Equity | ₹59.19 Cr | 3.54% |
ITC Ltd | Equity | ₹58.94 Cr | 3.52% |
Apollo Hospitals Enterprise Ltd | Equity | ₹57.45 Cr | 3.43% |
Tata Consultancy Services Ltd | Equity | ₹57.01 Cr | 3.41% |
ICICI Lombard General Insurance Co Ltd | Equity | ₹56.14 Cr | 3.36% |
Torrent Pharmaceuticals Ltd | Equity | ₹55.73 Cr | 3.33% |
UltraTech Cement Ltd | Equity | ₹54.53 Cr | 3.26% |
HCL Technologies Ltd | Equity | ₹54.3 Cr | 3.25% |
Dr Reddy's Laboratories Ltd | Equity | ₹54.22 Cr | 3.24% |
Havells India Ltd | Equity | ₹52.33 Cr | 3.13% |
Colgate-Palmolive (India) Ltd | Equity | ₹49.91 Cr | 2.98% |
Siemens Ltd | Equity | ₹48.77 Cr | 2.92% |
TVS Motor Co Ltd | Equity | ₹48.27 Cr | 2.89% |
Infosys Ltd | Equity | ₹48.02 Cr | 2.87% |
Info Edge (India) Ltd | Equity | ₹47.58 Cr | 2.84% |
Bajaj Auto Ltd | Equity | ₹46.8 Cr | 2.80% |
Tech Mahindra Ltd | Equity | ₹46.56 Cr | 2.78% |
Cummins India Ltd | Equity | ₹46.32 Cr | 2.77% |
Bosch Ltd | Equity | ₹45.17 Cr | 2.70% |
MRF Ltd | Equity | ₹41.92 Cr | 2.51% |
Zydus Lifesciences Ltd | Equity | ₹40.73 Cr | 2.43% |
State Bank of India | Equity | ₹40.2 Cr | 2.40% |
Treps | Cash - Repurchase Agreement | ₹0.38 Cr | 0.02% |
Net Current Assets | Cash | ₹-0.34 Cr | 0.02% |
Large Cap Stocks
83.99%
Mid Cap Stocks
16.01%
Small Cap Stocks
--
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹427.7 Cr | 25.57% |
Consumer Defensive | ₹229.13 Cr | 13.70% |
Technology | ₹205.89 Cr | 12.31% |
Consumer Cyclical | ₹182.15 Cr | 10.89% |
Basic Materials | ₹178.82 Cr | 10.69% |
Financial Services | ₹171.05 Cr | 10.22% |
Industrials | ₹147.41 Cr | 8.81% |
Communication Services | ₹130.67 Cr | 7.81% |
Standard Deviation
This fund
16.44%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.54
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2021
Since February 2024
Since November 2024
ISIN INF109KC17V7 | Expense Ratio 0.41% | Exit Load - | Fund Size ₹1,673 Cr | Age 4 years 8 months | Lumpsum Minimum - | Fund Status Open Ended Investment Company | Benchmark Nifty Alpha Low-Volatility 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Motilal Oswal Nifty Capital Market ETF Very High Risk | 0.3% | - | ₹5.38 Cr | - |
Mirae Asset BSE Select IPO ETF Very High Risk | - | - | ₹14.61 Cr | - |
Motilal Oswal Active Momentum Fund Direct Growth Very High Risk | 2.6% | 1.0% | ₹46.20 Cr | - |
Motilal Oswal Active Momentum Fund Regular Growth Very High Risk | 2.7% | 1.0% | ₹46.20 Cr | - |
Nippon India Active Momentum Fund Regular Growth Very High Risk | - | 1.0% | ₹130.97 Cr | - |
Nippon India Active Momentum Fund Direct Growth Very High Risk | - | 1.0% | ₹130.97 Cr | - |
Groww Nifty 200 ETF Very High Risk | 0.3% | - | ₹13.49 Cr | - |
Invesco India Business Cycle Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹267.72 Cr | - |
Invesco India Business Cycle Fund Regular Growth Very High Risk | 2.3% | 0.0% | ₹267.72 Cr | - |
Kotak MSCI India ETF Very High Risk | 0.4% | - | ₹1018.03 Cr | - |
Your principal amount will be at Very High Risk
EquityEquity - OtherVery High Risk
NAV (17-Apr-25)
Returns (Since Inception)
Fund Size
₹1,673 Cr
Expense Ratio
0.41%
ISIN
INF109KC17V7
Minimum SIP
-
Exit Load
-
Inception Date
12 Aug 2020
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
-1.04%
— (Cat Avg.)
3 Years
+15.07%
— (Cat Avg.)
Since Inception
+22.93%
— (Cat Avg.)
Equity | ₹1,672.82 Cr | 100.00% |
Others | ₹0.04 Cr | 0.00% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹85.24 Cr | 5.10% |
Bharti Airtel Ltd | Equity | ₹83.09 Cr | 4.97% |
ICICI Bank Ltd | Equity | ₹74.71 Cr | 4.47% |
Divi's Laboratories Ltd | Equity | ₹72 Cr | 4.30% |
Pidilite Industries Ltd | Equity | ₹64.6 Cr | 3.86% |
Lupin Ltd | Equity | ₹62.34 Cr | 3.73% |
United Spirits Ltd | Equity | ₹61.1 Cr | 3.65% |
Grasim Industries Ltd | Equity | ₹59.69 Cr | 3.57% |
Britannia Industries Ltd | Equity | ₹59.19 Cr | 3.54% |
ITC Ltd | Equity | ₹58.94 Cr | 3.52% |
Apollo Hospitals Enterprise Ltd | Equity | ₹57.45 Cr | 3.43% |
Tata Consultancy Services Ltd | Equity | ₹57.01 Cr | 3.41% |
ICICI Lombard General Insurance Co Ltd | Equity | ₹56.14 Cr | 3.36% |
Torrent Pharmaceuticals Ltd | Equity | ₹55.73 Cr | 3.33% |
UltraTech Cement Ltd | Equity | ₹54.53 Cr | 3.26% |
HCL Technologies Ltd | Equity | ₹54.3 Cr | 3.25% |
Dr Reddy's Laboratories Ltd | Equity | ₹54.22 Cr | 3.24% |
Havells India Ltd | Equity | ₹52.33 Cr | 3.13% |
Colgate-Palmolive (India) Ltd | Equity | ₹49.91 Cr | 2.98% |
Siemens Ltd | Equity | ₹48.77 Cr | 2.92% |
TVS Motor Co Ltd | Equity | ₹48.27 Cr | 2.89% |
Infosys Ltd | Equity | ₹48.02 Cr | 2.87% |
Info Edge (India) Ltd | Equity | ₹47.58 Cr | 2.84% |
Bajaj Auto Ltd | Equity | ₹46.8 Cr | 2.80% |
Tech Mahindra Ltd | Equity | ₹46.56 Cr | 2.78% |
Cummins India Ltd | Equity | ₹46.32 Cr | 2.77% |
Bosch Ltd | Equity | ₹45.17 Cr | 2.70% |
MRF Ltd | Equity | ₹41.92 Cr | 2.51% |
Zydus Lifesciences Ltd | Equity | ₹40.73 Cr | 2.43% |
State Bank of India | Equity | ₹40.2 Cr | 2.40% |
Treps | Cash - Repurchase Agreement | ₹0.38 Cr | 0.02% |
Net Current Assets | Cash | ₹-0.34 Cr | 0.02% |
Large Cap Stocks
83.99%
Mid Cap Stocks
16.01%
Small Cap Stocks
--
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹427.7 Cr | 25.57% |
Consumer Defensive | ₹229.13 Cr | 13.70% |
Technology | ₹205.89 Cr | 12.31% |
Consumer Cyclical | ₹182.15 Cr | 10.89% |
Basic Materials | ₹178.82 Cr | 10.69% |
Financial Services | ₹171.05 Cr | 10.22% |
Industrials | ₹147.41 Cr | 8.81% |
Communication Services | ₹130.67 Cr | 7.81% |
Standard Deviation
This fund
16.44%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.54
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2021
Since February 2024
Since November 2024
ISIN INF109KC17V7 | Expense Ratio 0.41% | Exit Load - | Fund Size ₹1,673 Cr | Age 4 years 8 months | Lumpsum Minimum - | Fund Status Open Ended Investment Company | Benchmark Nifty Alpha Low-Volatility 30 TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Motilal Oswal Nifty Capital Market ETF Very High Risk | 0.3% | - | ₹5.38 Cr | - |
Mirae Asset BSE Select IPO ETF Very High Risk | - | - | ₹14.61 Cr | - |
Motilal Oswal Active Momentum Fund Direct Growth Very High Risk | 2.6% | 1.0% | ₹46.20 Cr | - |
Motilal Oswal Active Momentum Fund Regular Growth Very High Risk | 2.7% | 1.0% | ₹46.20 Cr | - |
Nippon India Active Momentum Fund Regular Growth Very High Risk | - | 1.0% | ₹130.97 Cr | - |
Nippon India Active Momentum Fund Direct Growth Very High Risk | - | 1.0% | ₹130.97 Cr | - |
Groww Nifty 200 ETF Very High Risk | 0.3% | - | ₹13.49 Cr | - |
Invesco India Business Cycle Fund Direct Growth Very High Risk | 0.6% | 0.0% | ₹267.72 Cr | - |
Invesco India Business Cycle Fund Regular Growth Very High Risk | 2.3% | 0.0% | ₹267.72 Cr | - |
Kotak MSCI India ETF Very High Risk | 0.4% | - | ₹1018.03 Cr | - |
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments